First-Line Treatment with Bevacizumab and Platinum Doublet Combination in Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Cohort Study in US Oncology Community Practices

Lignende værker

• Clinical outcomes with bevacizumab-containing and non-bevacizumab–containing regimens in patients with recurrent glioblastoma from US community practices
  af: Chen, Clara, et al.
  Udgivet: (2015)
• First-line pemetrexed-platinum doublet chemotherapy with or without bevacizumab in non-squamous non-small cell lung cancer: A real-world propensity score-matched study in China
  af: Qi, Fei, et al.
  Udgivet: (2019)
• Phase II Study of a Non-platinum-containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab (PPB) as Initial Therapy for Patients with Advanced Lung Adenocarcinomas
  af: Pietanza, Catherine M., et al.
  Udgivet: (2016)
• Bevacizumab in Pediatric Neuro-Oncology
  af: Jacob Silverman, et al.
  Udgivet: (2025-10-01)
• Doublet chemotherapy with cisplatin and pemetrexed is associated with a favorable outcome in patients with advanced non-squamous non-small-cell lung cancer who are eligible for bevacizumab and maintenance therapy
  af: Nakashima, Kazuhisa, et al.
  Udgivet: (2016)